Showing 6231-6240 of 21464 results for "".
- Optimizing Parkinson’s Care and Combating Clinician Burnout through Multidisciplinary Approacheshttps://reachmd.com/news/optimizing-parkinsons-care-and-combating-clinician-burnout-through-multidisciplinary-approaches/2475924/In inpatient neurology units, efforts to optimize Parkinson’s disease therapies through a multidisciplinary approach and address specialist burnout are leading to adjustments in clinical practice. According to
- Adapting Cefiderocol Testing Amid Rising AMR: Exploring Mycoviral Solutionshttps://reachmd.com/news/adapting-cefiderocol-testing-amid-rising-amr-exploring-mycoviral-solutions/2475925/Amid a surge in multidrug-resistant Gram-negative infections, ensuring accurate cefiderocol susceptibility testing has become a clinical imperative, even as agricultural research explores mycoviral diversity to curb fungal resistance. Cefiderocol’s novel siderophore mechanism offers a crit
- Balancing Lifestyle Factors for Cognitive Longevity in Seniorshttps://reachmd.com/news/balancing-lifestyle-factors-for-cognitive-longevity-in-seniors/2475929/Cognitive decline in older adults threatens functional autonomy, yet emerging evidence suggests that modifiable lifestyle and environmental factors—from moderate coffee intake to proximity to natural settings—may tip the balance in favor of sustained brain function and longevity. Cli
- Exploring the Emerging Role of Plant-Derived Exosomes in Scar Managementhttps://reachmd.com/news/exploring-the-emerging-role-of-plant-derived-exosomes-in-scar-management/2475891/Plant-derived exosomes are being explored for their potential to modulate inflammation and stimulate regenerative pathways, aiming to improve healing outcomes in scar repair. Scar management remains a persistent challenge for dermatologists and plastic surgeons, with conventional mod
- Predicting Aggressive Endometrial Cancer with HOXA5https://reachmd.com/news/predicting-aggressive-endometrial-cancer-with-hoxa5/2475893/With the incidence of endometrial cancer rising steadily, oncologists face persistent gaps in accurately predicting which patients will progress to aggressive disease—gaps that the homeobox gene HOXA5 may help bridge. In oncology practice, real-world data reveal that HOXA5 expression
- Report: GLP-1s Dethrone Skincare Shifting Medical Aesthetic Spendhttps://reachmd.com/news/report-glp-1s-dethrone-skincare-shifting-medical-aesthetic-spend/2475902/Weight-loss medications continue to impact the medical aesthetics industry. GLP-1s surpassed skincare as the top consumer spend category, according to a new report from Guidepoint Qsight. Guidepoint Qsight found patients are focusing on the overall wellness journey, prioritizing bundling
- NPF and Boehringer Unite to Launch First GPP Awareness Dayhttps://reachmd.com/news/NPF-Boehringer-Unite-Launch-First-GPP-Awareness-Day/2475890/Key Takeaways NPF and Boehringer Ingelheim launched a campaign to educate and support individuals with generalized pustular psoriasis.
- Balancing Act: Screw vs. Suture Fixation in Tibial Eminence Fractureshttps://reachmd.com/news/balancing-act-screw-vs-suture-fixation-in-tibial-eminence-fractures/2475872/Tibial eminence fractures demand a precise balance between stabilization and complication risk, yet surgeons often lack clear guidance on whether to favor screw or suture fixation. As sports-related knee injuries rise in competitive and recreational athletes, orthopedic surgeons face
- Navigating the Evidence: OTC Supplements in Depression Treatmenthttps://reachmd.com/news/navigating-the-evidence-otc-supplements-in-depression-treatment/2475882/Primary care specialists are increasingly asked to integrate over-the-counter supplements into depression treatment, even as robust evidence to support their use remains elusive. Patients frequently seek complementary therapies in depression, driven by anxiety over side effe
- Harnessing AI and Preventive Surgery to Transform Breast Cancer Carehttps://reachmd.com/news/harnessing-ai-and-preventive-surgery-to-transform-breast-cancer-care/2475866/Emerging AI platforms are being developed to enhance the precision of targeting cancer cells, while expanding preventive surgical options may reduce breast cancer incidence in high-risk women. Oncologists today must navigate the integration of advanced artificial intelligence tools w